Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Queiroz, João
and
El-Hani, Charbel Niño
2006.
Towards a Multi-Level Approach to the Emergence of Meaning Processes in Living Systems.
Acta Biotheoretica,
Vol. 54,
Issue. 3,
p.
179.
Oresic, Kristina
Noriega, Vanessa
Andrews, Laura
and
Tortorella, Domenico
2006.
A Structural Determinant of Human Cytomegalovirus US2 Dictates the Down-regulation of Class I Major Histocompatibility Molecules.
Journal of Biological Chemistry,
Vol. 281,
Issue. 28,
p.
19395.
Pao, Lily I.
Badour, Karen
Siminovitch, Katherine A.
and
Neel, Benjamin G.
2007.
Nonreceptor Protein-Tyrosine Phosphatases in Immune Cell Signaling.
Annual Review of Immunology,
Vol. 25,
Issue. 1,
p.
473.
Rawson, Robert B.
2008.
Intriguing parasites and intramembrane proteases: Figure 1..
Genes & Development,
Vol. 22,
Issue. 12,
p.
1561.
Arnellos, Argyris
Bruni, Luis Emilio
El-Hani, Charbel Niño
and
Collier, John
2012.
Anticipatory Functions, Digital-Analog Forms and Biosemiotics: Integrating the Tools to Model Information and Normativity in Autonomous Biological Agents.
Biosemiotics,
Vol. 5,
Issue. 3,
p.
331.
Xie, Lan
Sullivan, Amy L.
Collier, Jana G.
and
Glass, Christopher K.
2013.
Serum Response Factor Indirectly Regulates Type I Interferon-Signaling in Macrophages.
Journal of Interferon & Cytokine Research,
Vol. 33,
Issue. 10,
p.
588.
Harnett, William
2014.
Secretory products of helminth parasites as immunomodulators.
Molecular and Biochemical Parasitology,
Vol. 195,
Issue. 2,
p.
130.
Rana, Aarti
Ahmed, Mushtaq
Rub, Abdur
and
Akhter, Yusuf
2015.
A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases.
Virulence,
Vol. 6,
Issue. 6,
p.
566.
Aguayo, Vasti
Valdés Fernandez, Bianca N.
Rodríguez-Valentín, Madeline
Ruiz-Jiménez, Caleb
Ramos-Benítez, Marcos J.
Méndez, Loyda B.
and
Espino, Ana M.
2019.
Fasciola hepatica GST downregulates NF-κB pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model.
Scientific Reports,
Vol. 9,
Issue. 1,
Wei, Penglu
Wang, Pengqian
Li, Bing
Gu, Hao
Liu, Jun
and
Wang, Zhong
2020.
Divergence and Convergence of Cerebral Ischemia Pathways Profile Deciphers Differential Pure Additive and Synergistic Mechanisms.
Frontiers in Pharmacology,
Vol. 11,
Issue. ,
Castelo-Soccio, Leslie
Kim, Hanna
Gadina, Massimo
Schwartzberg, Pamela L.
Laurence, Arian
and
O’Shea, John J.
2023.
Protein kinases: drug targets for immunological disorders.
Nature Reviews Immunology,
Vol. 23,
Issue. 12,
p.
787.
Masuda, Satohiro
Lemaitre, Florian
Barten, Markus J.
Bergan, Stein
Shipkova, Maria
van Gelder, Teun
Vinks, Sander
Wieland, Eberhard
Bornemann-Kolatzki, Kirsten
Brunet, Mercè
de Winter, Brenda
Dieterlen, Maja-Theresa
Elens, Laure
Ito, Taihei
Johnson-Davis, Kamisha
Kunicki, Pawel K.
Lawson, Roland
Lloberas, Nuria
Marquet, Pierre
Millan, Olga
Mizuno, Tomoyuki
Moes, Dirk Jan A. R.
Noceti, Ofelia
Oellerich, Michael
Pattanaik, Smita
Pawinski, Tomasz
Seger, Christoph
van Schaik, Ron
Venkataramanan, Raman
Walson, Phil
Woillard, Jean-Baptiste
and
Langman, Loralie J.
2024.
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Therapeutic Drug Monitoring,